Research Topics
| Michael J SilverbergSummaryAffiliation: Kaiser Permanente Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Prescription long-term opioid use in HIV-infected patientsMichael J Silverberg
Kaiser Permanente Northern California, Oakland, CA 94612, USA
Clin J Pain 28:39-46. 2012..To examine changes the in use of prescription opioids for the management of chronic noncancer pain in human immunodeficiency virus (HIV)-infected patients and to identify patient characteristics associated with long-term use...- Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North AmericaMichael J Silverberg
Division of Research, Kaiser Permanente Northern California, Oakland, CA 94612, USA
Clin Infect Dis 54:1026-34. 2012..There are also conflicting data regarding calendar trends... - Age and racial/ethnic differences in the prevalence of reported symptoms in human immunodeficiency virus-infected persons on antiretroviral therapyMichael J Silverberg
Department of Epidemiology, Johns Hopkins University, Baltimore, Maryland, USA
J Pain Symptom Manage 38:197-207. 2009..Clinicians should consider these factors when counseling patients regarding potential adverse effects of antiretrovirals or symptoms associated with HIV disease... - Race/ethnicity and risk of AIDS and death among HIV-infected patients with access to careMichael J Silverberg
Division of Research, Kaiser Permanente Northern California, Oakland, CA 94612, USA
J Gen Intern Med 24:1065-72. 2009..Prior studies evaluating racial/ethnic differences in responses to antiretroviral therapy (ART) among HIV-infected patients have not adequately accounted for many potential confounders, and few have included Hispanic patients... 
Response to newly prescribed lipid-lowering therapy in patients with and without HIV infectionMichael J Silverberg
Kaiser Permanente Northern California, Oakland, California, USA
Ann Intern Med 150:301-13. 2009..Antiretroviral agents, particularly protease inhibitors (PIs), may adversely affect lipid levels in patients with HIV infection. However, it is not known whether HIV-associated dyslipidemia is more difficult to treat...- HIV infection and the risk of cancers with and without a known infectious causeMichael J Silverberg
Division of Research, Kaiser Permanente Northern California, 2000 Broadway, Oakland, CA 94612, USA
AIDS 23:2337-45. 2009..To evaluate the risk of cancers with and without a known infectious cause in HIV-infected persons... - AIDS-defining and non-AIDS-defining malignancies: cancer occurrence in the antiretroviral therapy eraMichael J Silverberg
Division of Research, Kaiser Permanente Northern California, Oakland 94612, USA
Curr Opin Oncol 19:446-51. 2007..Effective antiretroviral therapy use has resulted in a large number of older individuals living with HIV. Recent literature is reviewed with respect to the incidence and risk factors for cancer in HIV patients... - Older age and the response to and tolerability of antiretroviral therapyMichael J Silverberg
Division of Research, Kaiser Permanente Northern California, 2000 Broadway, Oakland, CA 94612, USA
Arch Intern Med 167:684-91. 2007..The unique health needs of a growing older adult population infected with human immunodeficiency virus (HIV) require study, especially in terms of the response to and tolerability of highly active antiretroviral therapy (HAART)... - Effectiveness of highly-active antiretroviral therapy by race/ethnicityMichael J Silverberg
Department of Epidemiology, Johns Hopkins University, Bloomberg School of Public Health, Baltimore, Maryland, USA
AIDS 20:1531-8. 2006..To determine the effectiveness of HAART by race/ethnicity... - Serological detection of human papillomavirus type 16 infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative womenMichael J Silverberg
Department of Epidemiology, Johns Hopkins University, Bloomberg School of Public Health, Baltimore, Maryland, USA
Clin Vaccine Immunol 13:511-9. 2006..Rises among HIV-positive women may more often result from reactivation of a latent HPV infection in the context of HIV-induced immunosuppression, while rises among HIV-negative women may more often result from reinfection with HPV... - Prevalence of clinical symptoms associated with highly active antiretroviral therapy in the Women's Interagency HIV StudyMichael J Silverberg
Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA
Clin Infect Dis 39:717-24. 2004..The extended use of antiretroviral drugs among human immunodeficiency virus (HIV)-seropositive individuals underscores the need for a comprehensive evaluation of therapy-associated clinical symptoms... - HIV infection, immunodeficiency, viral replication, and the risk of cancerMichael J Silverberg
Kaiser Permanente Northern California, Oakland, CA 94612, USA
Cancer Epidemiol Biomarkers Prev 20:2551-9. 2011..Few studies have compared cancer risk between HIV-infected individuals and a demographically similar HIV-uninfected internal comparison group, adjusting for cancer risk factors... - Do antiretrovirals reduce the risk of non-AIDS-defining malignancies?Michael J Silverberg
Division of Research, Kaiser Permanente Northern California, Oakland, CA 94612, USA
Curr Opin HIV AIDS 4:42-51. 2009..There is an increasing burden of non-AIDS-defining malignancies (NADMs) in the antiretroviral therapy (ART) era. The recent literature is reviewed with respect to NADM risk, ART use, and immune function... - Age and gender trends in long-term opioid analgesic use for noncancer painCynthia I Campbell
Division of Research, Kaiser Permanente Northern California, Oakland, CA 94612, USA
Am J Public Health 100:2541-7. 2010..We describe age and gender trends in long-term use of prescribed opioids for chronic noncancer pain in 2 large health plans... - Virologic and immunologic response to HAART, by age and regimen classKeri N Althoff
Johns Hopkins University, Baltimore, Maryland 21287, USA
AIDS 24:2469-79. 2010..To determine the impact of age and initial HAART regimen class on virologic and immunologic response within 24 months after initiation... - Clinical course of recurrent respiratory papillomatosis in Danish childrenMichael J Silverberg
Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA
Arch Otolaryngol Head Neck Surg 130:711-6. 2004..To evaluate the clinical course of juvenile-onset recurrent respiratory papillomatosis (RP) with respect to age, disease duration, and maternal condylomas... 
Exposure to antiretroviral therapy and risk of cancer in HIV-infected personsChun Chao
aKaiser Permanente Southern California, Pasadena bKaiser Permanente Northern California, Oakland, California cMid Atlantic Permanente Research Institute, Rockville, Maryland dKaiser Permanente Northern California, Hayward eKaiser Permanente Southern California, Los Angeles fSan Francisco General Hospital gUniversity of California San Francisco, San Francisco, California, USA
AIDS 26:2223-31. 2012..Studies are needed to directly evaluate the effect of ART use on cancer risk...- Risk of cancers during interrupted antiretroviral therapy in the SMART studyMichael J Silverberg
Division of Research, Kaiser Permanente Northern California, Oakland, California 94110, USA
AIDS 21:1957-63. 2007..To compare rates of AIDS-defining and non-AIDS-defining malignancies between patients on a CD4 T-cell-guided antiretroviral therapy (ART) strategy and continuous ART... - CD4 count at presentation for HIV care in the United States and Canada: are those over 50 years more likely to have a delayed presentation?Keri N Althoff
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 N Wolfe St, Baltimore, MD, 21205, USA
AIDS Res Ther 7:45. 2010..10%, respectively). Due to the increasing proportion, consistently lower CD4 counts, and more advanced HIV disease in adults ≥50-year-old at first presentation for HIV care, renewed HIV testing efforts are needed... - The impact of HIV infection and immunodeficiency on human papillomavirus type 6 or 11 infection and on genital wartsMichael J Silverberg
Johns Hopkins School of Public Health, Baltimore, Maryland 21205, USA
Sex Transm Dis 29:427-35. 2002..CONCLUSIONS: HIV infection and immunodeficiency synergistically modified the relation between HPV 6 or 11 infection and genital wart prevalence... - Determination of optimized multidisciplinary care team for maximal antiretroviral therapy adherenceMichael A Horberg
Mid Atlantic Permanente Research Institute, Rockville, MD 20852, USA
J Acquir Immune Defic Syndr 60:183-90. 2012..We seek to determine the optimized multidisciplinary care team (MDCT) composition for antiretroviral therapy (ART) adherence... - Late presentation for human immunodeficiency virus care in the United States and CanadaKeri N Althoff
Johns Hopkins University, Baltimore, Maryland, USA
Clin Infect Dis 50:1512-20. 2010..CONCLUSION. CD4 count at first presentation for HIV care has increased annually over the past 11 years but has remained <350 cells/mm(3), which suggests the urgent need for earlier HIV diagnosis and treatment... - Syphilis epidemiology and clinical outcomes in HIV-infected and HIV-uninfected patients in Kaiser Permanente Northern CaliforniaMichael A Horberg
Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA
Sex Transm Dis 37:53-8. 2010..We describe differences between HIV-infected and HIV-uninfected patients diagnosed with syphilis within Kaiser Permanente Northern California... - Smoking enhances risk for new external genital warts in menDorothy J Wiley
Division of Primary Care, School of Nursing, University of California at Los Angeles UCLA, Los Angeles, California, USA
Int J Environ Res Public Health 6:1215-34. 2009..Multivariate analyses showed smoking, prior episodes of EGWs, HIV infection and CD4+ T-lymphocyte count among the infected, each differentially influenced the risk for new EGWs... - Condyloma in pregnancy is strongly predictive of juvenile-onset recurrent respiratory papillomatosisMichael J Silverberg
Department of Epidemiology, Baltimore, Maryland 21205 2179, USA
Obstet Gynecol 101:645-52. 2003.... - Trends in prescribed opioid therapy for non-cancer pain for individuals with prior substance use disordersConstance M Weisner
Department of Psychiatry, University of California, San Francisco, CA 94143, USA
Pain 145:287-93. 2009.... - The epidemiology of herpes zoster in patients with newly diagnosed cancerLaurel A Habel
Division of Research, Kaiser Permanente, Northern California, Oakland, CA, USA
Cancer Epidemiol Biomarkers Prev 22:82-90. 2013..Given the limited literature, we conducted a study to examine the epidemiology of herpes zoster (HZ) among newly diagnosed cancer patients... - Incidence of cervical squamous intraepithelial lesions associated with HIV serostatus, CD4 cell counts, and human papillomavirus test resultsTiffany G Harris
Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY 10461, USA
JAMA 293:1471-6. 2005.... - Effect of antiretroviral therapy on the incidence of genital warts and vulvar neoplasia among women with the human immunodeficiency virusL Stewart Massad
Southern Illinois University School of Medicine, Springfield, Illinois 62794 9640, USA
Am J Obstet Gynecol 190:1241-8. 2004..The purpose of this study was to determine the incidence and predictors of genital warts and vulvar intraepithelial neoplasia among women with the human immunodeficiency virus... - Prospective study of attitudinal and relationship predictors of sexual risk in the multicenter AIDS cohort studyDavid G Ostrow
David Ostrow and Associates, Chicago MACS Howard Brown Health Center and Northwestern University School of Medicine, 5455 N Sheridan Rd, Suite 1207, Chicago, IL 60640, USA
AIDS Behav 12:127-38. 2008..We conclude that HIV prevention efforts should target modifiable attitudes (reduced concern about HIV and safer sex fatigue) and increases in sexual risk-taking of MSM, particularly among HIV+ men having sex with serodiscordant partners... - CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infectionJason V Baker
University of Minnesota, Minneapolis, USA
AIDS 22:841-8. 2008..Reductions in AIDS-related morbidity and mortality following the advent of combination antiretroviral therapy have coincided with relative increases in chronic non-AIDS end-organ diseases among HIV+ patients... - Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive womenHoward D Strickler
Department of Epidemiology and Population Health, Albert Einstein College of Medicine, 1300 Morris Park Ave, Belfer 1308, Bronx, NY 10461, USA
J Natl Cancer Inst 97:577-86. 2005.... - How condom use, number of receptive anal intercourse partners and history of external genital warts predict risk for external anal wartsD J Wiley
Division of Primary Care, School of Nursing, UCLA, Los Angeles, CA 90095 6919, USA
Int J STD AIDS 16:203-11. 2005.... - Timing and completeness of routine testing for antibodies to human immunodeficiency virus type 1 among active duty members of the U.S. Armed ForcesMichael J Silverberg
Army Medical Surveillance Activity, Walter Reed Army Medical Center, Washington, DC 20307, USA
Mil Med 168:160-4. 2003..The results of this analysis may inform the planning and conduct of human immunodeficiency virus type 1 prevention programs as well as deployment-related or other surveillance activities...
Research Grants
- HIV Infection, Antiretroviral Therapy, Cancer Incidence and ProgressionMichael Silverberg; Fiscal Year: 2007..The results of this research may be informative to those providing care to HIV-infected patients with or at-risk for cancer. ..